131 related articles for article (PubMed ID: 28653237)
1. The Economic Burden of Insulin-Related Hypoglycemia in Spain.
Parekh W; Hoskins N; Baker-Knight J; Ramirez de Arellano A; Mezquita Raya P
Diabetes Ther; 2017 Aug; 8(4):899-913. PubMed ID: 28653237
[TBL] [Abstract][Full Text] [Related]
2. The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
Parekh W; Streeton SE; Baker-Knight J; Montagnoli R; Nicoziani P; Marchesini G
Diabetes Ther; 2018 Jun; 9(3):1037-1047. PubMed ID: 29600505
[TBL] [Abstract][Full Text] [Related]
3. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
[TBL] [Abstract][Full Text] [Related]
4. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool.
Parekh WA; Ashley D; Chubb B; Gillies H; Evans M
Diabet Med; 2015 Sep; 32(9):1156-66. PubMed ID: 25816891
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.
Morales C; de Luis D; de Arellano AR; Ferrario MG; Lizán L
Diabetes Ther; 2015 Dec; 6(4):593-610. PubMed ID: 26589521
[TBL] [Abstract][Full Text] [Related]
7. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus.
Oyagüez I; Merino-Torres JF; Brito M; Bellido V; Cardona-Hernandez R; Gomez-Peralta F; Morales-Perez F
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32699114
[TBL] [Abstract][Full Text] [Related]
8. The burden of severe hypoglycemia in type 1 diabetes.
Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
Curr Med Res Opin; 2018 Jan; 34(1):171-177. PubMed ID: 29019269
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
10. Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain.
Osumili B; Artime E; Mitchell B; Rubio-de Santos M; Díaz-Cerezo S; Giménez M; Spaepen E; Sharland H; Valentine WJ
Diabetes Ther; 2022 Apr; 13(4):775-794. PubMed ID: 35297026
[TBL] [Abstract][Full Text] [Related]
11. The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring.
Bronstone A; Graham C
J Diabetes Sci Technol; 2016 Jul; 10(4):905-13. PubMed ID: 26880392
[TBL] [Abstract][Full Text] [Related]
12. The burden of severe hypoglycemia in type 2 diabetes.
Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
Curr Med Res Opin; 2018 Jan; 34(1):179-186. PubMed ID: 29017368
[TBL] [Abstract][Full Text] [Related]
13. Costs associated with emergency care and hospitalization for severe hypoglycemia.
Veronese G; Marchesini G; Forlani G; Saragoni S; Degli Esposti L; Centis E; Fabbri A;
Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):345-51. PubMed ID: 26897390
[TBL] [Abstract][Full Text] [Related]
14. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of hypoglycemia on healthcare in Spain.
Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
[TBL] [Abstract][Full Text] [Related]
16. Self-reported frequency and impact of hypoglycemic events in Spain.
Orozco-Beltrán D; Mezquita-Raya P; Ramírez de Arellano A; Galán M
Diabetes Ther; 2014 Jun; 5(1):155-68. PubMed ID: 24515748
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective.
Mezquita-Raya P; Darbà J; Ascanio M; Ramírez de Arellano A
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):587-595. PubMed ID: 28649881
[TBL] [Abstract][Full Text] [Related]
18. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
Hellmund R; Weitgasser R; Blissett D
Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
